Schering to globalize clinical trial management
Executive Summary
Schering-Plough plans to globalize its clinical trial operations as part of its action agenda initiated in 2003 which seeks to transform the company into a high-performance competitor. Schering expects its Global Clinical Harmonization program will ensure better planning, prioritization, consistency and, as a result, improve efficiencies. One change will see the integration of Phase IV studies under the same roof as earlier development areas. Schering announced that it entered the "turnaround" phase of its action agenda late last year (1"The Pink Sheet" Nov. 7, 2005, p. 18). The globalization of clinical trial activities is not expected to result in head-count reductions...